spacer
home > pmps > summer 2007 > making gas a quality issue
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making Gas a Quality Issue

As the drive for quality continues, regulatory framework surrounding emissions control tightens. Lieve de Paepe at Air Products urges the pharmaceutical industry to foster close partnerships with suppliers to achieve compliance and improve efficiency

Generally used for only the most demanding industrial applications, pharmaceutical manufacturers use speciality gases for a wide range of specialist applications. These applications range from environmental monitoring and control, to using the gas as a key component of the production process itself. For example, many manufacturers use nitrogen as an inerting gas to prevent chemical reactions during production and packaging processes. At other times, pure gases, such as oxygen, are used to create the required reactions or to encourage microbe culture growth. Speciality gases are commonly used in the laboratory and in the area of R&D, and can even be used to carry out specific production processes, such as chemical synthesis. With such critical uses in mind, demand for quality has never been higher, and manufacturers need to be sure that the gas products they are using will deliver the highest standards of accuracy and consistency.

SOURCING HIGH GRADE GASES

When sourcing the highest grade speciality gases, first and foremost manufacturers tend to select those that fulfil the requirements of the monographs of the European, US and Japanese Pharmacopoeias. These standards are widely recognised by manufacturers and gas suppliers alike. In addition, the recent introduction of directives 2004/27/EC and 2004/28/EC (amending directives 2001/83/EC and 2001/82/EC), concerning the use of active pharmaceutical ingredients (API) for human and veterinary use, requires manufacturers to provide an assurance of quality and traceability at every stage of the production process from R&D, through to production and analysis. As part of this requirement, manufacturers must use high grade speciality gases, which have been produced according to good manufacturing practice (GMP) part II.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
Lieve de Paepe joined Air Products in 1990 after graduating as a Chemical Engineer from the University of Ghent, Belgium. In her current role, Lieve is responsible for supporting the development of speciality gases for a wide range of industrial applications in the pharmaceutical, chemical and environmental management sectors.
spacer
Lieve de Paepe
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Non-invasive SONOFLOW | Flow Sensors and SONOFLOW | C Software: The user-friendly smart sensoring package for application in laboratory 4.0, R&D, and single-use production environments

With the influence of digitization and increasing needs for process monitoring, laboratory, R&D, and single-use production environments are changing rapidly. Networked laboratory devices with smart functions, automation concepts, and efficient interface solutions have altered laboratory workflows and stand for the new era of Lab 4.0. Therefore, a rising tide of the continuous availability of data requires an easy data handling and secure data logging.
More info >>

White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement